Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors.


Journal

Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557

Informations de publication

Date de publication:
02 2019
Historique:
received: 26 04 2018
accepted: 11 10 2018
pubmed: 26 10 2018
medline: 11 2 2020
entrez: 26 10 2018
Statut: ppublish

Résumé

The aim of this study was to examine the relationship between employment and financial toxicity by examining the prevalence of, and factors associated with, financial toxicity among cancer survivors. We conducted a secondary analysis of a sub-sample from the Dutch Patient Reported Outcomes Following Initial Treatment and Long-term Evaluation of Survivorship (PROFILES) registry. Descriptive statistics, bivariate analysis and logistic regression were used. A total of 2931 participants with diverse cancer types were included in the analysis with a mean age of 55 years (range 18 to 65). Nearly half (49%) of participants were employed at the time of the survey, and 22% reported financial toxicity. Those who were not employed were at greater risk of financial toxicity (27% vs 16%, p < 0.001), and this did not vary according to time since diagnosis. The odds of reporting financial toxicity were greater for participants who were male, younger, unmarried, with low education, low socioeconomic status, or without paid employment. Those with basal cell carcinoma had lower risk of financial toxicity, while those with haematological or colorectal cancer had highest risk of financial toxicity. This research confirms that unemployment is significantly associated with financial toxicity and that those with limited financial resources are most at risk. Increased awareness of financial toxicity and its associated factors among clinicians may result in improved screening and appropriate referrals for support services. The implementation of effective multidisciplinary return to work interventions, as part of standard cancer survivorship care, may reduce financial toxicity among cancer survivors.

Identifiants

pubmed: 30357537
doi: 10.1007/s11764-018-0723-7
pii: 10.1007/s11764-018-0723-7
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-20

Références

Oncologist. 2001;6(5):435-40
pubmed: 11675521
Cancer. 2016 Apr 15;122(8):283-9
pubmed: 26991528
J Natl Cancer Inst. 2016 Oct 20;109(2):
pubmed: 27754926
Lancet Haematol. 2015 Oct;2(10):e408-16
pubmed: 26686042
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Cancer. 2017 Feb 1;123(3):476-484
pubmed: 27716900
Oncologist. 2013;18(4):381-90
pubmed: 23442307
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 28771857
Med J Aust. 2016 Jun 20;204(11):397
pubmed: 27318391
J Clin Oncol. 2012 May 10;30(14):1608-14
pubmed: 22412136
Occup Environ Med. 2010 Sep;67(9):639-48
pubmed: 20798030
Patient. 2017 Jun;10(3):295-309
pubmed: 27798816
Health Aff (Millwood). 2013 Dec;32(12):2205-15
pubmed: 24226092
Occup Med (Lond). 2009 Sep;59(6):373-7
pubmed: 19692522
Support Care Cancer. 2013 Jan;21(1):107-17
pubmed: 22987093
BMC Public Health. 2014 Sep 17;14:963
pubmed: 25230842
Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007569
pubmed: 21328297
Cancer. 2015 Dec 15;121(24):4425-32
pubmed: 26501494
Oncology (Williston Park). 2013 Feb;27(2):80-1, 149
pubmed: 23530397
J Clin Oncol. 2013 Oct 20;31(30):3749-57
pubmed: 24043731
Crit Rev Oncol Hematol. 2011 Feb;77(2):109-30
pubmed: 20117019
J Oncol Pract. 2014 Sep;10(5):332-8
pubmed: 24865220
Psychooncology. 2002 Mar-Apr;11(2):124-31
pubmed: 11921328
Acta Oncol. 2007;46(4):446-51
pubmed: 17497311
Eur J Cancer. 2011 Sep;47(14):2188-94
pubmed: 21621408
Support Care Cancer. 2006 Nov;14(11):1077-85
pubmed: 16896878

Auteurs

Alison Pearce (A)

Centre for Health Economics Research and Evaluation, University of Technology Sydney, PO Box 123, Broadway, NSW, 2007, Australia. Alison.pearce@chere.uts.edu.au.

Bianca Tomalin (B)

Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia.

Billingsley Kaambwa (B)

Health Economics Unit, Flinders University, Adelaide, Australia.

Nicole Horevoorts (N)

Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.
Department of Research, The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

Saskia Duijts (S)

Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of General Practice, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Floortje Mols (F)

Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.
Department of Research, The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

Lonneke van de Poll-Franse (L)

Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.
Department of Research, The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Bogda Koczwara (B)

Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH